Back to Learn

Manufacturing & cGMP

What Does Cell Passage Number Mean in Exosome Manufacturing?

Passage number describes how much cultured cells have been expanded. Why it's a legitimate manufacturing question for cultured-cell-derived EV products — and why it doesn't apply to every EV source.

August 18, 2026 5 min read

If you're comparing extracellular-vesicle products made from cultured cells, you may encounter a technical term that rarely appears in marketing:

Passage number.

It sounds like a minor laboratory detail, but it can tell you something important about how the cells used during production have been expanded.

And if a company is producing EVs from cultured cells, it's a reasonable manufacturing question to ask.

What Is a Cell Passage?

Cells grown in a laboratory are typically maintained in culture.

As those cells grow and multiply, they eventually occupy the available space or reach a density where they need to be transferred into new culture vessels.

That process is called passaging or subculturing.

Each round of continued culture and expansion contributes to the cells' passage history.

In simple terms:

Original cells → Expansion → Passage → More expansion → Another passage

Passaging allows researchers and manufacturers to generate larger populations of cells.

But cells aren't necessarily identical forever.

Why Does Passage Number Matter?

Cells are biological systems, not photocopies.

As cultured cells undergo repeated expansion, their characteristics can change.

Research involving mesenchymal stromal/stem cells (MSCs), for example, has documented changes associated with extended culture and replicative senescence. Research has also shown that senescence can alter characteristics of the extracellular vesicles those cells release.

That matters because the cells are the source of a cultured-cell-derived EV preparation.

If the source cells change, it's reasonable to ask whether the EVs they produce may change as well.

Does a Higher Passage Number Mean Worse Exosomes?

This needs some nuance.

Higher passage does not create a universal point at which an EV product suddenly becomes “bad.”

There isn't one passage number that can be applied to every cell type, culture system and manufacturing process as the dividing line between good and bad EVs.

However, that doesn't mean passage number is irrelevant.

Repeated cell expansion can be associated with changes in cell phenotype, function and senescence, which can also influence the EVs those cells release.

So when cultured cells are being used to manufacture an EV product, passage history and controls over cell expansion are legitimate quality considerations.

The question isn't simply:

“Is this passage 3 or passage 7?”

It's:

“How does the manufacturer control its cell source and expansion process?”

What Should You Ask a Supplier?

If you're evaluating a cultured-cell-derived EV product, consider asking:

  • What type of cells produce the EVs?
  • Where did the original cells come from?
  • Are the cells expanded before EV collection?
  • Is passage number monitored?
  • Is there a maximum passage used for production?
  • How does the manufacturer evaluate consistency as cells are expanded?
  • Can the supplier provide documentation about its manufacturing controls?

A knowledgeable supplier should at least understand why those questions matter.

Be more cautious if a seller claims to offer a cultured-cell-derived EV product but cannot provide meaningful information about the cells used to produce it. See Red Flags to Look Out for When Purchasing Exosomes.

Passage Number Doesn't Apply to Every EV Source

This distinction is especially important.

Not every EV product is produced by growing cells in culture.

Extracellular vesicles can also be obtained from naturally occurring biological fluids.

According to KWEHEALTH's supplied documentation, HydroKarma is derived from refined amniotic fluid. It is not produced by expanding cultured cells to generate EVs.

Therefore, cell passage number should not be treated as a HydroKarma manufacturing specification.

That's why knowing the source of an EV product matters before asking manufacturing questions.

For a cultured-cell-derived product, passage history may be highly relevant.

For a biological-fluid-derived product, different sourcing, processing, purification and characterization questions become more relevant.

See Where Do Exosomes Come From? Comparing Common Sources.

Don't Let One Number Replace the Bigger Picture

Passage number shouldn't become another marketing number like particle count.

A company advertising “low passage” hasn't automatically demonstrated that its finished product is high quality.

You still need to evaluate:

Source → Manufacturing controls → Processing → Purification → Characterization → Finished-product testing → Documentation

The same principle we've used throughout this Learn library applies here, as How to Evaluate an Exosome Product Before You Buy explains:

One measurement or manufacturing detail rarely tells the whole story.

The Bottom Line

For extracellular-vesicle products produced from cultured cells, cell passage history matters because repeated expansion can change the cells—and changes in the cells can influence the EVs they release.

That makes passage number and cell-expansion controls reasonable questions for buyers to ask.

But passage number isn't a universal quality score, and there is no single passage number that automatically separates a good EV product from a bad one.

Most importantly, determine how the EV product is sourced before applying cultured-cell manufacturing questions to it.

HydroKarma, according to KWEHEALTH's supplied documentation, is derived from refined amniotic fluid rather than cultured-cell expansion, so cell passage number isn't the appropriate metric for evaluating its manufacturing process.

Original Source / References

  1. Welsh JA, Goberdhan DCI, O'Driscoll L et al. — Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. Journal of Extracellular Vesicles, 2024;13(2):e12404. DOI: 10.1002/jev2.12404 (PMID 38326288). Cited for EV nomenclature and the recommendation that EV preparations be characterized rather than described by name or a single number alone.
  2. Wagner W, Horn P, Castoldi M et al. — Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE, 2008;3(5):e2213. DOI: 10.1371/journal.pone.0002213 (PMID 18493317). Cited for the general point that MSC characteristics change continuously during extended culture and replicative senescence. It does not define a universal maximum passage number.
  3. Kim CG, Lee JK, Cho GJ, Shin OS, Gim JA — Small RNA sequencing of small extracellular vesicles secreted by umbilical cord mesenchymal stem cells following replicative senescence. Genes & Genomics, 2023;45(3):347–358. DOI: 10.1007/s13258-022-01297-y (PMID 35917089). Cited for the general point that replicative senescence can alter the cargo of MSC-derived small EVs. It concerns cultured MSCs and does not concern HydroKarma.
  4. KWEHEALTH/HydroKarma — manufacturer-supplied documentation regarding HydroKarma sourcing and manufacturing. The statement that HydroKarma is derived from refined amniotic fluid rather than cultured-cell expansion is manufacturer-supplied information; it is not a finding of the independent publications above and does not establish safety or efficacy.